MycoBiomDB – Record Details (MyCo_3110)

Biomarker Record Details

Database ID: MyCo_3110
DB IDMyCo_3110
TitleCan bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections
Year2012
PMID21907303
Fungal Diseases involvedInvasive fungal infection
Associated Medical ConditionBacteraemia
GenusNone
SpeciesNone
OrganismNone
Ethical StatementThis study was conducted at the Erciyes University Hospital, a 1300-bed tertiary care centre in Kayseri, Turkey. The study was approved by the ethics board of the Medical Faculty. The records of the Infection Control Committee were reviewed to identify the patients with bacteraemia who were hospitalized in the haematology ward and stem cell transplantation unit. All medical records, laboratory data, and discharge summaries were evaluated to identify the cases.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameBDG
Biomarker Full Name1-3-beta-D-Glucan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationTurkey
CohortPatients who had undergone the BDG test at least once within 5 days of a positive blood culture were included in the study. BDG levels in the sera were assayed using the Fungitell kit (Associates of Cape Cod, East Falmouth, MA) according to the manufacturer’s specifications. Eighty-three bacteraemic episodes were identified in 71 patients. BDG positivity was detected in 14 patients with bacteraemia.
Cohort No.71
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueELISA
Analysis MethodFDA approved Fungitell assay
ELISA kitsNone
Assay DataFDA approved Fungitell assay
Validation Techniques usedFDA approved Fungitell assay
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone